PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 30 filers reported holding PHARMACYTE BIOTECH INC in Q2 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46,452 | -16.6% | 23,700 | +0.9% | 0.00% | – |
| Q1 2024 | $55,695 | +11.1% | 23,500 | +1.3% | 0.00% | – |
| Q4 2023 | $50,112 | +2.4% | 23,200 | -0.4% | 0.00% | – |
| Q3 2023 | $48,930 | -27.2% | 23,300 | -0.9% | 0.00% | -100.0% |
| Q2 2023 | $67,210 | -3.8% | 23,500 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $69,840 | -5.4% | 24,000 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $73,836 | +23.1% | 25,200 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $60,000 | +1.7% | 24,800 | -5.3% | 0.00% | 0.0% |
| Q2 2022 | $59,000 | -1.7% | 26,200 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $60,000 | -21.1% | 26,300 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | -72.9% | 30,400 | -65.5% | 0.00% | -66.7% |
| Q3 2021 | $280,000 | – | 88,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 276,992 | $792,197 | 4.95% |
| K2 PRINCIPAL FUND, L.P. | 154,232 | $441,104 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 61,415 | $175,647 | 0.05% |
| CSS LLC/IL | 13,186 | $37,712 | 0.00% |
| Covestor Ltd | 189 | $1 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,500 | $67,210 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,288 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 54 | $154 | 0.00% |
| WELLS FARGO & COMPANY/MN | 185 | $529 | 0.00% |
| NORTHERN TRUST CORP | 28,415 | $81,267 | 0.00% |